🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Obecholic acid is a modified bile acid and Farnesoid X receptor (FXR) agoni...
Status
Completed
Location
Beijing Friendship Hospital
Start Date
2021-09-23
Trial ID
NCT05450887
Treatments Being Tested
This is an investigator-initiated, double-blind crossover study on the mech...
Status
Completed
Location
Susanne Keiding
Start Date
2016-05-19
Trial ID
NCT03253276
Treatments Being Tested
The main purpose of this study is to see whether heavy drinking will interf...
Status
Completed
Location
Indiana University
Start Date
2016-04
Trial ID
NCT02654236
Treatments Being Tested
The main objectives of the study were to assess the effects of Obeticholic ...
Status
Completed
Location
UC Davis Medical Center
Start Date
2012-01
Trial ID
NCT01473524
Treatments Being Tested
This study will evaluate the efficacy, safety and tolerability, as well as ...
Status
Terminated
Location
Queensland Childrens Hospital
Start Date
2024-09-02
Trial ID
NCT06121375
Treatments Being Tested
This was a phase 2, double-blind (DB), placebo-controlled trial in particip...
Status
Completed
Location
St. Joseph's Hospital & Medical Center
Start Date
2015-02-09
Trial ID
NCT02177136
Treatments Being Tested
Study to determine the effect of the investigational drug bezafibrate (BZF)...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-03-21
Trial ID
NCT05239468
The primary hypothesis was that obeticholic acid (OCA) will cause a reducti...
Status
Completed
Location
Henry Ford
Start Date
2008-01-17
Trial ID
NCT00570765
Treatments Being Tested
Primary Biliary Cholangitis (PBC) is a serious, life-threatening, bile acid...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2014-12-26
Trial ID
NCT02308111
Treatments Being Tested
Administration of the farnesoid X receptor (FXR) ligand obeticholic acid (O...
Status
Completed
Location
University of California, San Diego
Start Date
2011-03
Trial ID
NCT01265498
Treatments Being Tested